Dillon Cockrell, MD· @DCockrellMD · X·· 18 小时前评分45
正文 · 机器翻译
很高兴看到 @BGarmezy 展示这些数据。期待这项面向 #prostatecancer 男性患者的新潜在疗法，也期待参与 @DukeCancer 的相关工作。感谢 @OncHahn 的辛勤付出和领导！
#ESMO26 @AarmstrongDuke @OncoAlert @myESMO @oncodaily @OncoDailyGU @urotoday
137 浏览 · 3 赞 · 1 转发 · 0 回复
Thrilled to share updated results from JNJ-6143, the AR-BRD4 RIPTAC therapy, presented by @BGarmezy. Totally novel MOA was well tolerated, oral pill and produced significant benefit for pts (PSA90 50%, ORR 68%). P2 trial active now and more coming. Lots of potential!在 X 查看被引用的帖子
来源：Dillon Cockrell, MD · x.com